219 related articles for article (PubMed ID: 12460877)
21. Increased plasma angiotensin II in postural tachycardia syndrome (POTS) is related to reduced blood flow and blood volume.
Stewart JM; Glover JL; Medow MS
Clin Sci (Lond); 2006 Feb; 110(2):255-63. PubMed ID: 16262605
[TBL] [Abstract][Full Text] [Related]
22. Treatment of chronic orthostatic hypotension with ergotamine.
Chobanian AV; Tifft CP; Faxon DP; Creager MA; Sackel H
Circulation; 1983 Mar; 67(3):602-9. PubMed ID: 6295662
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of clonidine and dihydroergotamine on venomotor tone and orthostatic tolerance in patients with severe hypoadrenergic orthostatic hypotension.
Victor RG; Talman WT
Am J Med; 2002 Apr; 112(5):361-8. PubMed ID: 11904110
[TBL] [Abstract][Full Text] [Related]
24. Certain cardiovascular indices predict syncope in the postural tachycardia syndrome.
Sandroni P; Opfer-Gehrking TL; Benarroch EE; Shen WK; Low PA
Clin Auton Res; 1996 Aug; 6(4):225-31. PubMed ID: 8902319
[TBL] [Abstract][Full Text] [Related]
25. Role of {alpha}1-adrenergic vasoconstriction in the regulation of skeletal muscle blood flow with advancing age.
Wray DW; Nishiyama SK; Richardson RS
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H497-504. PubMed ID: 19060122
[TBL] [Abstract][Full Text] [Related]
26. Effect of a neck compression collar on cardiorespiratory and cerebrovascular function in postural orthostatic tachycardia syndrome (POTS).
Nardone M; Guzman J; Harvey PJ; Floras JS; Edgell H
J Appl Physiol (1985); 2020 Apr; 128(4):907-913. PubMed ID: 32163327
[TBL] [Abstract][Full Text] [Related]
27. Alpha-adrenergic vascular responsiveness during postexercise hypotension in humans.
Halliwill JR; Dinenno FA; Dietz NM
J Physiol; 2003 Jul; 550(Pt 1):279-86. PubMed ID: 12766237
[TBL] [Abstract][Full Text] [Related]
28. Decreased microvascular nitric oxide-dependent vasodilation in postural tachycardia syndrome.
Medow MS; Minson CT; Stewart JM
Circulation; 2005 Oct; 112(17):2611-8. PubMed ID: 16230486
[TBL] [Abstract][Full Text] [Related]
29. A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome.
Ross AJ; Ocon AJ; Medow MS; Stewart JM
Clin Sci (Lond); 2014 Feb; 126(4):289-96. PubMed ID: 23978222
[TBL] [Abstract][Full Text] [Related]
30. Role of sympathetic responses on the hemodynamic consequences of rapid changes in posture in humans.
Sheriff DD; Nådland IH; Toska K
J Appl Physiol (1985); 2010 Mar; 108(3):523-32. PubMed ID: 20056846
[TBL] [Abstract][Full Text] [Related]
31. Attenuated peripheral vasoconstriction during an orthostatic challenge in older men.
Groothuis JT; Thijssen DH; Kooijman M; Paulus R; Hopman MT
Age Ageing; 2008 Nov; 37(6):680-4. PubMed ID: 18829692
[TBL] [Abstract][Full Text] [Related]
32. Continuous progression of orthostatic tachycardia as a further feature of the postural tachycardia syndrome.
Diehl RR
Pacing Clin Electrophysiol; 2005 Sep; 28(9):975-9. PubMed ID: 16176538
[TBL] [Abstract][Full Text] [Related]
33. Clinical and laboratory indices that enhance the diagnosis of postural tachycardia syndrome.
Novak V; Novak P; Opfer-Gehrking TL; O'Brien PC; Low PA
Mayo Clin Proc; 1998 Dec; 73(12):1141-50. PubMed ID: 9868411
[TBL] [Abstract][Full Text] [Related]
34. Reduced body mass index is associated with increased angiotensin II in young women with postural tachycardia syndrome.
Stewart JM; Taneja I; Medow MS
Clin Sci (Lond); 2007 Dec; 113(11):449-57. PubMed ID: 17624938
[TBL] [Abstract][Full Text] [Related]
35. Phenylephrine alters phase synchronization between cerebral blood velocity and blood pressure in ME/CFS with orthostatic intolerance.
Medow MS; Stewart JM
Am J Physiol Regul Integr Comp Physiol; 2024 Jun; 326(6):R599-R608. PubMed ID: 38682242
[TBL] [Abstract][Full Text] [Related]
36. Orthostatic challenge reveals impaired vascular resistance control, but normal venous pooling and capillary filtration in familial dysautonomia.
Brown CM; Stemper B; Welsch G; Brys M; Axelrod FB; Hilz MJ
Clin Sci (Lond); 2003 Feb; 104(2):163-9. PubMed ID: 12546638
[TBL] [Abstract][Full Text] [Related]
37. Heart rate and plasma cyclic AMP responses to isoproterenol infusion and effect of beta-adrenergic blockade in patients with postural orthostatic tachycardia syndrome.
Abe H; Nagatomo T; Kohshi K; Numata T; Kikuchi K; Sonoda S; Mizuki T; Kuroiwa A; Nakashima Y
J Cardiovasc Pharmacol; 2000; 36 Suppl 2():S79-82. PubMed ID: 11206727
[TBL] [Abstract][Full Text] [Related]
38. Reflex vascular defects in the orthostatic tachycardia syndrome of adolescents.
Stewart JM; Weldon A
J Appl Physiol (1985); 2001 Jun; 90(6):2025-32. PubMed ID: 11356761
[TBL] [Abstract][Full Text] [Related]
39. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders.
Shibao C; Arzubiaga C; Roberts LJ; Raj S; Black B; Harris P; Biaggioni I
Hypertension; 2005 Mar; 45(3):385-90. PubMed ID: 15710782
[TBL] [Abstract][Full Text] [Related]
40. Autonomic modulation of the U wave during phenylephrine and esmolol infusions.
Magnano AR; Suleman S; Garan H; Bloomfield DM
J Electrocardiol; 2005 Apr; 38(2):152-6. PubMed ID: 15892026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
